chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Woke up morning of Friday, April 9 with sinus pressure in the head.  By 12pm same day running low-grade headache and both hands were very cold.  By 3pm same day had elevated temperature (running warm), did not take temperature.  By 5:30pm same day strong headache and still running warm, was tired.  Took 2 Tylenol (500mg each) for the headache.  By 10pm same day all side-effects and symptoms were gone and felt back to normal.
2 1/2" X 2 1/4" - redness, swelling and area is much hotter than skin around this area.
It was reported that a 42 year old female pt received Fluzone SV '99-'00 vaccination on 11/30/99. Reportedly, the pt experienced immediate pain at the injection site. The pt has experienced pain "shooting" down arm occasionally since the vaccination was given. The pt was seen by her physician on 12/7/99 and was dx'd with rotator cuff tendonitis. From correspondence received on 1/28/00, additional pt, responsible physician and vaccine information was provided.
Stroke - (Rt) middle cerebral artery occlusion on 4/23/10. Care for stroke & PT.
On day of 1st vaccine dose, my shoulder was in pain when I attempted to lift it laterally to the side and a audible popping was present near shoulder.   Vaccine was given around 3pm and pain began around 9pm. Exactly 1 week after 2nd dose, shoulder blade pain began on same side that shoulder pain was present.  Shoulder blade and shoulder pain still persists to date (3.5 months since first dose). Treatment included rest and physical therapy, with no success.
pt recv vax 15OCT97 & approx 1hr p/vax pt exp severe hypothermia, n/v & abd pain which persists today;
PATIENT HAS A RED SPOT THAT IS SLIGHTLY RAISED AND IS 2 INCHES BY 2.5 INCHES IN SIZE. THIS WAS MEASURED 2 DAYS AFTER THE VACCINE WAS ADMINISTERED. HE WAS INSTRUCTED TO TAKE 50 MG OF BENADRYL EVERY 4-6 HOURS AND TO CONTINUE MEASURING THE SPOT AT HOME. IF IT HAS GROWN, THE PATIENT IS INSTRUCTED TO GO TO THE HOSPITAL.
On 11/13/2022 I went on my usual walk and about 30 minutes in I started feeling severe substernal pain; heart racing;diacritic; headache; low grade fever (99.9) ;I took my blood pressure and the monitor was not recording my BP at that time. A family member suggested I go to the ER.  When I arrived at the ER my BP was 139/96  and I was also experiencing frequent urination. I left the ER once my BP and Pulse were regulated. I have a follow up appointment on 11/23/2022.
Dizziness; This is a spontaneous report received from a contactable consumer who reported for himself via a sponsored program. A male patient of an unspecified age received his second single dose of bnt162b2 (Pfzier-BioNTech Covid-19 vaccine) in Feb2021 for Covid-19 immunization. The patient received his first dose of bnt162b2 on an unspecified date. The patient's medical history and concomitant medications were not reported. Since the second injection (Feb2021), the patient had complained that he had dizziness. He went to ENT and doctor and could find nothing wrong. The outcome of the event was unknown.   Information on the lot/batch number has been requested.
Injected Thurs. afternoon by Friday night experienced Flu-like symptoms. Low grade fever, muscle aches, joint aches, fatigue & chills. Took TYLENOL. 6/29 - feeling better.
Dry mouth; Extremely dry eyes; This is a spontaneous report from a contactable consumer, the patient. A 47-years-old non--pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot: en6208), via an unspecified route of administration in the right arm on 17Mar2021 at 1:45 PM (at the age of 47-years) as a single dose for COVID-19 immunisation. Medical history included migraines. Concomitant medications included loratadine (MANUFACTURER UNKNOWN) and BENADRYL. No other vaccine was received within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with covid-19 and was also not tested for COVID-19 since the vaccination. The patient experienced dry mouth and extremely dry eyes on 17Mar2021. No therapeutic measures were taken for the reported events. The clinical outcome of the events dry mouth and dry eyes were recovered on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
fever; feeling very sick; aches; feels very tired daily; This is a spontaneous report from a contactable consumer (patient) via Pfizer-sponsored program.  A female patient of an unspecified age received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on 23Feb2021 (Lot number was not reported) as SINGLE DOSE for covid-19 immunisation.  The patient's medical history and concomitant medications were not reported.  Historical vaccine includes dose 1 of BNT162B2 received on 02Feb2021. The patient experienced fever, feeling very sick, aches, feels very tired daily and stayed in bed all day. The outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
40 minutes p/vax pt devel what appeared to be a nickel sized hive above rt eyebrow in midline of forehead; c/o itching, bump, redness; no other c/o;
Note: following up after making the first VAERS report for Dose one- I received a test result of  lung test a couple of days before dose 2 where I found out my lung capacity at 45% and so they told me to get the second dose as soon as possible. I was still taking medication for Valley Fever at time of vaccine. Immediate affects after the 2nd vaccine - sore arm that lasted 24 hours.  In May, towards the end of month,  I was finally about to see the Valley Fever specialist. He told me that I could have  had such bad affects after the first vaccine that my immune system was very low. Then we had a very big tree removed from our yard and he said I could have gotten Valley Fever from all of that together.  I started having some headaches - continued - severe headaches. I had these from end of May until just a couple of weeks ago. They would wake me up. I haven't had the headaches now for last two weeks. No treatments. I am still on treatment for Valley Fever and I am continuing to need to monitor the lungs.
Patient received MMR and Hep B vaccine on 12/19/01. 12/27/01 she called to report sore throat and fever of 103. "Muscle weakness".
12/24/13=nausea, cough, felt rundown. 12/26/13=fever, pale,could not get out of bed. 1/2/2014=feeling better.
Patient received both vaccines in the same arm on 09/10/2020.  She called back to the pharmacy on 09/12/2020 and said that her arm was very painful and swollen.  She was encouraged by the pharmacy to take over the counter pain relievers and try using a ice pack to help with the pain and swelling.  She was also encouraged to seek medical attention if the pain/swelling didn't improve or got worse.  Her husband reported to the pharmacy on 09/13/2020 that she had been diagnosed with cellulitis and was given a prescription for an antibiotic and an anti-inflammatory medication.
The vaccine was maintained at proper refrigeration temperatures, but for longer than 31 days.  7/29/21 was day 31 at refrigeration temps and vaccine was given on 8/12/21.  No adverse events have been reported by patient.   Error discovered on 8/16/21
Moderna Covid 19 Vaccine EUA. I hope I read the lot number correctly. I can't discern it the 0 should be a O. This the what happened. I received dose #2 on 2/12 in the afternoon. Approximately ten hours later around 2:00am I had flu-like symptoms which included body aches, chills, fever, nasal congestion which lasted all of 2/13.  Upon awakening on 2/14 I noticed a bright red rash on the truck of my body (front and back.)  The flu symptoms have abated.
Body aches hips and all joints, neck and jaw muscles on right side going up to my right temple. Light sinus headache. Depression. Tylenol has helped.
Cellulitis( red arm wrapping around entire bicep) , Muscle pain, fatigue
This spontaneous report was received from a medical assistant and refers to a unspecified patients of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions and allergies and concomitant therapies was reported. On an unknown dates, multiple doses of improperly stored LIQUID PEDVAXHIB lot # M046140 with expiration date 27-SEP-2019 were administered to multiple unspecified patients for prophylaxis. Improperly stored vaccines underwent following temperature excursion: 9 Celsius degrees to 25 Celsius degrees (8.5 Celsius degrees) for 12 hours. Data logger was involved. No adverse event was reported.; Sender's Comments:  US-009507513-1708USA000956: US-009507513-1708USA005614: US-009507513-1708USA005616: US-009507513-1708USA005617:
I got a routine tetanus shot as part of general check-up.  The first day after the shot I was fine, but by evening time and in the two days that followed, my arm has been in pretty extreme pain.  It's been getting worse.  I can hardly lift my arm at all and can reach barely my mid chest.  I am unable to sleep because every moment I make hurts.  It's swollen and very hard to feel.  Last night I even had a nausea attack and almost vomited.  I have not vomited in many many years.  I'm waiting for the pain to subside.
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  It was reported that there had been no power outages that would have impacted the Moderna vaccine. However, the Healthcare professional reiterates that because facility was unable to download the digital data logger, they would need to treat this issue as a temperature excursion. The data logger was unable to download for the months of Dec-2021, Jan-2022, and Feb-2022. They were filling out a temperature excursion assessment with the State at that time. It was reported that no adverse reactions were reported by any patients.  No treatment medication was reported.   This case was linked to MOD-2022-501575 (Patient Link).
8 days after injection, a red patch developed just below the injection site.  It is approximately 3 inches in diameter and is hot to the touch.
Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 33-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     Concurrent medical conditions included Constipation, Iron deficiency and Headache. Concomitant products included DOCUSATE SODIUM (COLACE) from 2021 to an unknown date for Constipation, PARACETAMOL (TYLENOL) from 2020 to an unknown date for Headache, IRON from 2021 to an unknown date for Iron deficiency, MINERALS NOS, VITAMINS NOS (ONE A DAY [MINERALS NOS;VITAMINS NOS]) from 2020 to an unknown date for Pregnancy.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 20-Jul-2020 and the estimated date of delivery was 10-May-2021. On 02-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-second week of the pregnancy.  On 02-Mar-2021, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Sep-2020, Pregnancy test: positive (Positive) Positive. On an unknown date, Blood glucose: (normal) before vaccine. On an unknown date, Ultrasound scan: normal (normal) before vaccine.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Lab investigations included Anatomy scan and results were normal before vaccine. No treatment information was provided.
Fluarix QIV, Boostrix, and Shingrix vaccines that went below range for 11 hours to a low of -4.1 degrees Celsius, had been administered to patients; This case was reported by a pharmacist via call center representative and described the occurrence of incorrect storage of drug in an unspecified number patients who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2022-2023 season) for prophylaxis.  Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis, DTPa (Reduced antigen) (Boostrix) for prophylaxis and Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Fluarix Quadrivalent 2022-2023 season, Fluarix Tetra Pre-Filled Syringe Device, Boostrix and Shingrix. On an unknown date, unknown after receiving Fluarix Quadrivalent 2022-2023 season, Fluarix Tetra Pre-Filled Syringe Device, Boostrix and Shingrix, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 11-Oct-2022 Reporter's comment: The pharmacist reported via chat that Fluarix Quadrivalent, Boostrix, and Shingrix vaccines that went below range for 11 hours to a low of minus 4.1 degrees Celsius, had been administered to patients after the freezing excursion.   The chat session was ended by the reporter without providing any additional information and answering follow-up permission inquiry. The consent to follow-up was granted. Additional supportive information: The pharmacist reported via chat that Fluarix Quadrivalent, Boostrix, and Shingrix vaccines that went below range for 11 hours to a low of minus 4.1 degrees Celsius, had been administered to patients after the freezing excursion, which led to incorrect storage of drug.
Pt has redness, pain, feels hot at site of injection. Fever 100.4F. Started Keflex 500mg Tpo QID x 10 days per doctor. Pt to call if worsens or has red streaks on arm. Taking Ibuprofen.
Pt states he had a low grade fever and HSV 1 outbreak 2 days after getting vaccine.
About five days after receiving the vaccine I started having stomach pains it was persistent and nothing would help it so I knew it was the vaccine that caused my stomach problems. My doctor recommended to a Gastroenterologist. Nothing came of that so my regular medical doctor prescribe CYMBALTA and it got better but then I got COVID-19 and the stomach pains came back.
Patient unable to sleep due to right arm discomfort. Injection site warm to touch. Also painful to raise right arm over head. TX: Ice, Ibuprofen.
Shingles; This is a spontaneous report from a contactable physician reported for himself. A 56-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231, expiration date was not reported), via an unspecified route of administration on the left arm on 23Dec2020 07:30 at single dose for COVID-19 immunization. Medical history was reported as none. The patient has no allergies to medications, food, or other products. The patient received 'rovoustatin' within two weeks of vaccination. The patient experienced shingles on 27Dec2020. The patient received Valtrex as treatment for the event. The patient did not receive any other vaccine within four weeks prior to COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 since the vaccination. The patient recovered from the event on an unspecified date.
Client expressed fear with injection. Given in (L) arm. She reported pain in (L) arm. She began pallor and lightheaded, reported loss of hearing and vision, then had loss of consciousness along with body twitching. Within 2 seconds she required consciousness though remained distant in consciousness for several more seconds. She was given juice. given ice for her neck. She was moved to table to lie down. She c/o headache, lips returned to pink. Client walked to care nurse.
9/22/2021 9:20 am - rush of warmth, tightness in chest, lasting a minute or so 1:30 pm - same as above but less intense 7:00 pm - same as above but even milder no symptoms after 7 pm 9/22/2021
Received shot and that night my left arm from neck to finger tips hurts really bad.  Was given Rofecoxib.  Couldn't even lift a 20lb dumbell.
Septic shock secondary to urinary tract infection with Klebsiella. She was initiated on vancomycin and zosyn and was managed in the ED until bed availability at  ICU. The patient during the course of admission continued to have problems with hypotension. Eventually the patient blood pressure stabilized. She had been treated initially with Zosyn and vancomycin. Cultures eventually returned and was positive for evidence of Klebsiella and E. coli. Klebsiella was noted to be resistant to ampicillin and ciprofloxacin. The patient eventually was switched initially to just Zosyn. After sensitivities were known she was switched to ceftriaxone for treatment of her infection. The hypotension eventually resolved. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
A non-serious spontaneous report of administration of expired FLUMIST was received from a nurse concerning a 40 year old male. Neither medical history nor concomitant medications were reported. On 05-Feb-2009, the patient received expired FLUMIST vaccine. The vaccine had an expiration date of 11-Jan-2009. As of 18-Mar-20098, there was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved. Based on the results of the investigation, the root cause for the medication errors were caused by 1) customers not discarding product from previous season and 2) product expiring during the peak of flu season resulting in some medication errors that occurred shortly after the product expired. Follow-up information was received on 12-May-2009: Product Complaint Investigation results.
pt recv vax 17SEP96 & pt exp severe h/a 30min p/vax;pt seen by MD & a neurologist;ha/ were incapacitating;pt was prescribed Ibuprofen w/o significant relief;pt cont to exp severe h/a now 2w p/vax;pt exp fever, n/v, neck stiffness;flu synd;
High grade fever, diarrhea, vomit, nausea, splitting headache, chills, loss of appetite, muscle aches, jaw pain, lethargy, blurred vision.
Vaccine was administered post use date. Patient's provider, FNP contacted parents or guardian on 02/17/23 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it likely maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you may have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Pt recvd DTP/OPV/HIB immediately p/shot pale, unresponsive lasting 15 min;
Pain in side that gradually increase till the above cannot stand the led to gallbladder removal 06/19/2013. Severe tonsillitis leads to breathing problems and hospitalization. Still has not recovered 07/14/2013-07/16/2013= hospitalization. Symptoms still persist.
flu; the patient was readmitted to the hospital from 3/9/2020 through 3/12/2020 for vomiting and and bloody diarrhea; the patient was readmitted to the hospital from 3/9/2020 through 3/12/2020 for vomiting and and bloody diarrhea; This spontaneous report was received from a physician and refers to a infant female patient who was born with congenital diaphragmatic hernia and lung hypoplasia. The patient's medical history included hospitalization for two months after birth, due to congenital anomalies. There was no information about the patient's allergies, drug reactions or concomitant therapies provided. On unknown date in 2019, while hospitalization after birth, the patient was vaccinated with first dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) orally (dose, lot # and expiration date were not reported) for prophylaxis. On unknown date in February 2020, the patient was admitted to the hospital due to the flu. The patient sought medical attention and received unspecified treatment. While hospitalization G-tube was placed as well as Nissen fundoplication procedure due to congenital anomalies. During the admission, the patient was administered all age appropriate unspecified vaccines, except the second dose ofrotavirus vaccine, live, oral, pentavalent (ROTATEQ). Since 9-MAR-2020 to 12-MAR-2020, the patient was readmitted to the hospital because of vomiting and bloody diarrhea. The patient sought medical attention and received unspecified treatment.  The outcome of flu was unknown. The physiaican reported that the event of vomiting had resolved but the patient still had blood in stool.   The causality assessment between the events and rotavirus vaccine, live, oral, pentavalent (ROTATEQ) was not provided.   Upon internal review the event of bloody diarrhea (haematochezia) was considered to be medically significant.
A report was received from a health care professional on 11/11/03 concerning a 47 year old female vaccinee who experienced localized redness an unspecified time after inadvertently receiving a sub optimal dose of Fluvirin intradermally on 11/11/03. On 11/11/03 the vaccinee received 0.1ml Fluvirin intradermally. The vaccinee experienced injection site redness shortly after vaccination. The vaccinee had not recovered at the time of the report. There was insufficient information to determine the reporter's causality assessment. Update 1, 11/25/03: Follow up information received from a health care professional indicated that the vaccinee also experienced localized tenderness. The vaccinee recovered 6 days after the onset of the event. Cross reference with: PJP200301051 amd PJP200301049.
Dermatitis, raised, red, itchy bumps, covering most of body including scalp.
11/01/2021 I began walking to the bus at 7:45am I felt a bad pain in my chest, it lasted thru out the day.  I went into my doctor the same day.  I have Costo Chondrointis and it is still ongoing to this day.